Anti-CD46 antibody drug conjugate (Fortis Therapeutics)
- Generic Name
- Anti-CD46 antibody drug conjugate (Fortis Therapeutics)
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2
Not yet recruiting
- Conditions
- Metastatic Castration-Resistant Prostate Cancer
- Interventions
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- FibroGen
- Target Recruit Count
- 75
- Registration Number
- NCT06842498
- Locations
- ๐บ๐ธ
Astera Cancer Care, East Brunswick, New Jersey, United States
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
Phase 1
Recruiting
- Conditions
- Prostate CancerMetastatic Castration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2021-08-18
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- Rahul Aggarwal
- Target Recruit Count
- 36
- Registration Number
- NCT05011188
- Locations
- ๐บ๐ธ
University of California, San Francisco, San Francisco, California, United States
A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Phase 1
Completed
- Conditions
- Multiple MyelomaMultiple Myeloma With Failed RemissionMultiple Myeloma in Relapse
- Interventions
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Fortis Therapeutics, Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT03650491
- Locations
- ๐บ๐ธ
Icahn School of Medicine at Mt. Sinai, New York, New York, United States
๐บ๐ธKarmanos Cancer Institute, Detroit, Michigan, United States
๐บ๐ธUniversity of Colorado Cancer Center, Aurora, Colorado, United States
A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- First Posted Date
- 2018-07-03
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Fortis Therapeutics, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT03575819
- Locations
- ๐บ๐ธ
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
๐บ๐ธNorthwestern University, Chicago, Illinois, United States
๐บ๐ธOHSU Knight Cancer Institute, Portland, Oregon, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath